Skip to main content
. 2019 Apr 29;20(9):2108. doi: 10.3390/ijms20092108

Figure 2.

Figure 2

Results of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide cell-viability assay (MTT assay), showing the metabolic activity rates of hGFs, pre-treated or not with mitomycin C, exposed to sham, the SEMF, and the PEMF. Experiments were carried out in duplicate, and hGFs derived from all recruited patients were analyzed. Values are reported as the mean ± SD change with respect to sham-exposed hGFs assumed equal to 100% of activity. *** p-Value < 0.001 SEMF vs. sham.